
USFDA APPLICATION NUMBER - 50718 / DOSAGE - INJECTABLE, LIPOSOMAL;INJECTION - 20MG/10ML (2MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| doxorubicin hydrochloride(UNII: 82F2G7BL4E) (doxorubicin - UNII:80168379AG) | doxorubicin hydrochloride | 2mg in 1 |
Inactive Ingredients
| Ingredient Name | BluePoint Laboratories | Janssen Products, LP |
|---|---|---|
| AMMONIUM SULFATE(SU46BAM238) | ||
| cholesterol(97C5T2UQ7J) | ||
| HISTIDINE(4QD397987E) | ||
| hydrochloric acid(QTT17582CB) | ||
| hydrogenated soybean lecithin(H1109Z9J4N) | ||
| SODIUM HYDROXIDE(55X04QC32I) | ||
| SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(3L6NN8ZZKU) | ||
| SUCROSE(C151H8M554) |